State v. Troisi

2022 Ohio 3582, 206 N.E.3d 695, 169 Ohio St. 3d 514
CourtOhio Supreme Court
DecidedOctober 11, 2022
Docket2021-1182
StatusPublished
Cited by25 cases

This text of 2022 Ohio 3582 (State v. Troisi) is published on Counsel Stack Legal Research, covering Ohio Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State v. Troisi, 2022 Ohio 3582, 206 N.E.3d 695, 169 Ohio St. 3d 514 (Ohio 2022).

Opinion

[Until this opinion appears in the Ohio Official Reports advance sheets, it may be cited as State v. Troisi, Slip Opinion No. 2022-Ohio-3582.]

NOTICE This slip opinion is subject to formal revision before it is published in an advance sheet of the Ohio Official Reports. Readers are requested to promptly notify the Reporter of Decisions, Supreme Court of Ohio, 65 South Front Street, Columbus, Ohio 43215, of any typographical or other formal errors in the opinion, in order that corrections may be made before the opinion is published.

SLIP OPINION NO. 2022-OHIO-3582 THE STATE OF OHIO, APPELLEE, v. TROISI ET AL., APPELLANTS. [Until this opinion appears in the Ohio Official Reports advance sheets, it may be cited as State v. Troisi, Slip Opinion No. 2022-Ohio-3582.] Criminal law—Drug trafficking—R.C. 2925.03—R.C. Chapter 4729—Due Process Clauses of the Ohio and United States Constitutions—Due process requires that wholesale distributors of dangerous drugs charged with drug trafficking under R.C. 2925.03 for acting “not in accordance with R.C. Chapter 4729” be given notice in the indictment or by subsequent elucidation of the specific violation of R.C. Chapter 4729 that makes the wholesale distributor susceptible to indictment on charges of drug trafficking—Court of appeals’ judgment reversed and causes remanded to the trial court. (No. 2021-1182—Submitted June 16, 2022—Decided October 11, 2022.) APPEAL from the Court of Appeals for Cuyahoga County, Case Nos. 109871, 109874, 109875, and 109876, 2021-Ohio-2678. __________________ SUPREME COURT OF OHIO

KENNEDY, J. {¶ 1} In this discretionary appeal from a judgment of the Eighth District Court of Appeals, we are asked to determine what constitutes adequate notice to inform a wholesale distributor of the charges brought against it under Ohio’s drug- trafficking laws. Wholesale distributors are protected from prosecution for drug trafficking as long as they comply with the requirements of several chapters of the Revised Code, including R.C. Chapter 4729. R.C. 2925.03(B)(1). Here, we are asked to determine whether the state must provide a wholesale distributor charged with drug trafficking under R.C. 2925.03(A)(1) and (2) notice of the specific violation of R.C. Chapter 4729 that makes it susceptible to indictment on charges for drug trafficking. We hold that under the Due Process Clauses of the Ohio and United States Constitutions, the state must identify in an indictment, or by subsequently elucidating the indictment, the specific violation of R.C. Chapter 4729 that makes the accused susceptible to prosecution under R.C. 2925.03(A). The state’s failure to do so in these cases led the trial court to properly dismiss the indictment. We hold, however, that the trial court erred when it dismissed the indictment with prejudice. Because the Eighth District reversed the trial court’s holding on the adequacy of the notice, we reverse the court of appeals’ judgment. I. FACTUAL AND PROCEDURAL BACKGROUND A. The indictment {¶ 2} Appellants are Martek Pharmacal Company, a wholesale distributor of prescription weight-loss drugs; its owner, Andrew Steck; and two of its employees, Jon Troisi and Nicholas Troisi. It is undisputed that Martek conducts business with pharmacies and physicians nationwide and that it does not sell its weight-loss medications directly to any patient or consumer. At all relevant times, Martek was a properly licensed wholesale distributor in Ohio. See R.C. 4729.01(O). As agents or employees of Martek, the remaining appellants were also considered wholesale distributors under the statutory scheme.

2 January Term, 2022

{¶ 3} In September 2019, in a seven-count indictment, appellee, the state of Ohio, charged appellants with drug trafficking from February 1, 2014, to February 28, 2017. Five counts alleged violations of R.C. 2925.03(A)(1), which prohibits any person from knowingly selling or offering to sell a controlled substance. Those counts involved the sale of Adipex Phentermine 37.5 mg, a Schedule IV drug (Count 1); Adipex Phentermine 30 mg, a Schedule IV drug (Count 2); Phendimetrazine 105 mg, a Schedule III drug (Count 4); Diethylproprion 75 mg, a Schedule IV drug (Count 6); and Benzophetamine Hydrochloride 50 mg, a Schedule III drug (Count 7). Two other counts alleged violations of R.C. 2925.03(A)(2), under which no person shall “[p]repare for shipment, ship, transport, deliver, prepare for distribution, or distribute a controlled substance * * * when the offender knows or has reasonable cause to believe that the controlled substance * * * is intended for sale or resale by the offender or another person.” Those counts involved the intended sale or resale of Phendimetrazine 35 mg, a Schedule III drug (Count 3) and Diethylproprion 25 mg, a Schedule IV drug (Count 5). Count 7 alleged sales at or over 5 times the bulk amount; all other counts alleged sales over 50 times the bulk amount. The state’s crucial allegation, which is the focus of this appeal, was that appellants’ activities were “not in accordance with Chapter 4729 of the Ohio Revised Code.” {¶ 4} Because appellants are in the business of wholesale distribution, they were necessarily involved in selling or offering to sell controlled substances, R.C. 2925.03(A)(1), and preparing to distribute or distributing controlled substances, R.C. 2925.03(A)(2). The allegation that appellants acted “not in accordance with Chapter 4729” is central to this appeal because R.C. 2925.03(A) does not apply to “[m]anufacturers, licensed health professionals authorized to prescribe drugs, pharmacists, owners of pharmacies, and other persons whose conduct is in accordance with Chapter[] 4729 * * * of the Revised Code,” R.C. 2925.03(B)(1).

3 SUPREME COURT OF OHIO

{¶ 5} Therefore, in order for R.C. 2925.03(A)(1) and (2) to apply to appellants, they had to have acted not “in accordance with Chapter 4729,” R.C. 2925.03(B)(1). The state did not pinpoint in the indictment how appellants had opened themselves up to criminal liability under R.C. 2925.03(A)(1) and (2) by failing to comply with Chapter 4729. It alleged only that appellants had failed to be “in accordance with Chapter 4729 of the Ohio Revised Code.” B. Bill of particulars {¶ 6} The state provided a bill of particulars to appellants, but it essentially rephrased the language of the indictment and contained no specifics regarding how appellants had failed to comply with R.C. Chapter 4729. Appellants moved for a more specific bill of particulars, arguing that the state had “fail[ed] to describe the nature of the offenses charged or the conduct of each [appellant] it believes constitute[d] a violation of Ohio law.” {¶ 7} On March 9, 2020, at the hearing on the motion for a more specific bill of particulars, appellants argued that the state had “not met its burden to provide a bill of particulars that properly informs each [appellant] of the nature of the crimes they’re charged with, as well as the specific acts and instances that make up that criminal activity.” The trial court asked the state what part of R.C. Chapter 4729 appellants had violated. The state referred to “the one that says that prescribers cannot give out more than 2,500 pills a month. That’s the law in the State of Ohio.” The state alleged that appellants were providing up to 30,000 pills a month to five doctors who were under investigation for overprescribing the drugs. R.C. 4729.291(C)(1)(a) does prohibit prescribers from furnishing to patients over 2,500 dosage units a month of a controlled substance—but it does not address the amount that wholesale distributors may furnish to its consumers. At the hearing, the state pledged to provide further information to appellants about the individual drug sales at issue. In April 2020, the state provided a breakdown of the drug sales from Martek to five doctors.

4 January Term, 2022

C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Ngaide
2026 Ohio 478 (Ohio Court of Appeals, 2026)
State v. Cooper
2026 Ohio 101 (Ohio Court of Appeals, 2026)
State v. Crump
2025 Ohio 2962 (Ohio Court of Appeals, 2025)
State v. Dowell
2025 Ohio 2425 (Ohio Court of Appeals, 2025)
State v. Hopkins
2025 Ohio 2102 (Ohio Court of Appeals, 2025)
State v. Robinson
2025 Ohio 2026 (Ohio Court of Appeals, 2025)
State v. Hall
2025 Ohio 1644 (Ohio Court of Appeals, 2025)
United States v. Tyren Cervenak
135 F.4th 311 (Sixth Circuit, 2025)
State v. Mercer
2025 Ohio 1158 (Ohio Court of Appeals, 2025)
State v. Dixon
2025 Ohio 326 (Ohio Court of Appeals, 2025)
State v. Brown
2025 Ohio 8 (Ohio Court of Appeals, 2025)
State v. Thacker
2024 Ohio 5835 (Ohio Court of Appeals, 2024)
State v. Flantoill
2024 Ohio 5224 (Ohio Court of Appeals, 2024)
State v. Honeycutt
2024 Ohio 2507 (Ohio Court of Appeals, 2024)
State v. Jackson
2024 Ohio 2302 (Ohio Court of Appeals, 2024)
State v. Thompson
2024 Ohio 1285 (Ohio Court of Appeals, 2024)
State v. Shahin
2024 Ohio 456 (Ohio Court of Appeals, 2024)
State v. Petitto
2024 Ohio 186 (Ohio Court of Appeals, 2024)
State v. Boyd
2023 Ohio 4725 (Ohio Court of Appeals, 2023)
State v. Booker
2023 Ohio 4216 (Ohio Court of Appeals, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
2022 Ohio 3582, 206 N.E.3d 695, 169 Ohio St. 3d 514, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-v-troisi-ohio-2022.